Peter Barrett‐Lee
- Oncology top 1%
- HER2/EGFR in Cancer Research 28
- Cancer Treatment and Pharmacology 27
- Bone health and treatments 14
- Cancer Diagnosis and Treatment 8
- Cancer Research top 1%
- Breast Cancer Treatment Studies 35
- Hematology top 1%
- Erythropoietin and Anemia Treatment 8
- Biochemistry top 2%
- Radiation top 2%
-
- Estrogen and related hormone effects 14
-
- Advanced Breast Cancer Therapies 13
- Co-authors
- Judith M. BlissR. Charles CoombesPere GascónCarsten BokemeyerM. SchneiderDirk SchrijversM T TraversStephen Hiscox
- Cited by
- OncologyCancer ResearchHematology
- Journals
- Cancer Research (19 papers)British Journal of Cancer (10 papers)Journal of Clinical Oncology (9 papers)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Peter Barrett‐Lee
118 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 2.6k
- Cancer Research 1.4k
- Hematology 807
- Biochemistry 252
- Radiation 322
Countries citing papers authored by Peter Barrett‐Lee
This map shows the geographic impact of Peter Barrett‐Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Barrett‐Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Barrett‐Lee more than expected).
Fields of papers citing papers by Peter Barrett‐Lee
This network shows the impact of papers produced by Peter Barrett‐Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Barrett‐Lee. The network helps show where Peter Barrett‐Lee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Barrett‐Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2021 | 8 | |
| 3 | 2019 | 18 | |
| 4 | 2018 | 42 | |
| 5 | 2017 | 17 | |
| 6 | 2016 | 20 | |
| 7 | Subcutaneous trastuzumab (Herceptin®): A UK time and motion study in comparison with intravenous formulation for the treatment of patients with HER2-positive early breast cancer | 2015 | 1 |
| 8 | 2014 | 4 | |
| 9 | 2014 | 202 | |
| 10 | 2013 | 31 | |
| 11 | 2013 | 83 | |
| 12 | 2011 | 19 | |
| 13 | Human gammadelta T cell responses in breast cancer patients during zoledronate therapy | 2010 | 0 |
| 14 | 2006 | 61 | |
| 15 | 2005 | 22 | |
| 16 | 2005 | 121 | |
| 17 | 2000 | 127 | |
| 18 | 1994 | 11 | |
| 19 | 1993 | 68 | |
| 20 | 1992 | 165 |
About Peter Barrett‐Lee
Peter Barrett‐Lee is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Allergy and Hematology, having authored 121 papers that have together received 5.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (35 papers), HER2/EGFR in Cancer Research (28 papers), Cancer Treatment and Pharmacology (27 papers), Bone health and treatments (14 papers), Estrogen and related hormone effects (14 papers), Advanced Breast Cancer Therapies (13 papers), Erythropoietin and Anemia Treatment (8 papers) and Cancer Diagnosis and Treatment (8 papers). The work is most often cited by research in Oncology (2.6k citations), Cancer Research (1.4k citations), Hematology (807 citations), Biochemistry (252 citations) and Radiation (322 citations). Peter Barrett‐Lee has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Judith M. Bliss, R. Charles Coombes, Pere Gascón, Carsten Bokemeyer, M. Schneider, Dirk Schrijvers, M T Travers, Stephen Hiscox, Penelope Hopwood and Simon Van Belle. Their work appears in journals such as Cancer Research, British Journal of Cancer, Journal of Clinical Oncology, European Journal of Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.